Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Yinchenhao Decoction is a Traditional Chinese Medicine (TCM) herbal formula used for the treatment of liver and gallbladder disorders, specifically primary biliary cholangitis (PBC). It is a modified version of the classic Yinchenhao Decoction (Yinchenhao Tang), which typically consists of *Artemisia capillaris*, *Gardenia jasminoides*, and *Rheum palmatum*. The "Jiawei" (modified) version often includes additional herbs to enhance its effects on clearing heat, promoting diuresis, and resolving dampness and blood stasis. In clinical settings, it is being evaluated for its efficacy in improving liver function and clinical symptoms in PBC patients who exhibit the TCM pattern of dampness-heat stasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiawei Yinchenhao Decoction (Shanghai Pudong New Area Gongli Hospital).